BiotechTube
Home/Pipeline/Generic Portfolio Expansion - Anti-infectives

Generic Portfolio Expansion - Anti-infectives

Bacterial Infections

Regulatory SubmissionActiveN/A

Key Facts

Indication
Bacterial Infections
Phase
Regulatory Submission
Status
Active
Company
Alkaloid AD Skopje

About Alkaloid AD Skopje

Alkaloid's mission is to improve health and quality of life by providing high-quality, accessible pharmaceutical and consumer healthcare products. The company has achieved a dominant market position in Southeast Europe, established a resilient export business, and built a reputation for reliability over nearly nine decades. Its strategy is centered on leveraging its integrated operations, portfolio diversification, and regional distribution strength to drive sustainable growth in both domestic and international generic drug and consumer health markets.

View full company profile

Therapeutic Areas

CardiovascularCentral Nervous SystemGastrointestinalAnti-infectiveConsumer Health

Other Bacterial Infections Drugs

DrugCompanyPhase
Azithromycin Preparationscspc-pharmaceuticalCommercial
Penem Preparationscspc-pharmaceuticalCommercial
Various Penicillin/Cephalosporin Productscspc-pharmaceuticalCommercial
Nemonoxacin Malate CapsulesZhejiang MedicineCommercial
Clindamycin Phosphate InjectionViwitCommercial
Levofloxacin Hydrochloride InjectionViwitCommercial
Meropenem-VaborbactamSciClone PharmaceuticalsCommercial (in China)
Vibativ® (telavancin)Cleo Life SciencesApproved
Penicillin V APIBiotikaCommercial
Sterile Injectable Antibiotics PortfolioSteripharmaApproved
Oral AntibioticDawah PharmaceuticalsANDA Filed/Pre-approval
XAB05/XAB06XenotheraPreclinical